- 50+ clinical sites in Poland, Bulgaria
- 50+ investigators in endocrinology
Osteoporosis
- phase II trial in 160 female patients with bone density measurement
- phase III trial in 450 female patients
Hypercholesterolemia
- phase III trials in 120 patients
- seven phase III trials in over 2200 type 1 and type 2 diabetes patients